Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 98

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 98
---
 stock. If the shares of FutureTech’s common stock are subject to the “penny stock” rules, the holders of such shares of FutureTech’s common stock may find it more difficult to sell their shares.

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Since FutureTech’s common stock and public warrants are listed on Nasdaq, such securities qualify as covered securities under such statute. Although the states are preempted from regulating the sale of covered securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if the common stock, and public warrants were no longer listed on Nasdaq, these securities would not qualify as covered securities under such statute and FutureTech would be subject to regulation in each state in which it offers its securities.

We also note that if Nasdaq delists FutureTech’s securities from trading on its exchange, FutureTech will be required to apply for listing the combined company’s securities on Nasdaq, The fact that FutureTech’s securities are not listed on Nasdaq may present certain challenges to listing the post Business Combination combined company’s securities on Nasdaq, such as the post Business Combination combined company’s ability to meet the listing requirements for Nasdaq, including the minimum per share bid price and the market value of unrestricted publicly held shares.

Nasdaq may not list Longevity’s securities on its exchange, which could limit investors’ ability to make transactions in Longevity’s securities and subject Longevity to additional trading restrictions.

In connection with the Business Combination, in order to continue to maintain the listing Longevity will be required to demonstrate compliance with Nasdaq’s initial listing requirements, which are more rigorous than Nasdaq’s continued listing requirements. FutureTech will apply to have Longevity’s securities listed on Nasdaq upon consummation of the Business Combination. FutureTech cannot assure you that Longevity will be able to meet all initial listing requirements. Even if Longvity’s securities are